A carregar...

Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis from the JUPITER Trial

BACKGROUND: Lipoprotein(a) [Lp(a)] is an LDL-like particle largely independent of known risk factors and predictive of cardiovascular disease (CVD). Statins may offset the risk associated with elevated Lp(a), but it is unknown if Lp(a) is a determinant of residual risk in the setting of low LDL-chol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Khera, Amit V., Everett, Brendan M., Caulfield, Michael P., Hantash, Feras M., Wohlgemuth, Jay, Ridker, Paul M, Mora, Samia
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3946056/
https://ncbi.nlm.nih.gov/pubmed/24243886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.113.004406
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!